Status:
RECRUITING
Implementation of Bright Light Therapy ID
Lead Sponsor:
Erasmus Medical Center
Conditions:
Depressive Symptoms
Eligibility:
All Genders
18+ years
Brief Summary
Many adults with intellectual disabilities (ID) have depressive symptoms, which negatively impact their quality of life. A lot of of the non-medicinal forms of treatment are not or hardly suitable for...
Eligibility Criteria
Inclusion
- Involved in the implementation of BLT (staff) OR
- Involved in the prescription or application of BLT (staff/relatives) OR
- receiving BLT for their depressive symptoms (patients with ID)
- 18 years or older
- informed consent
Exclusion
- n/a
Key Trial Info
Start Date :
October 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT06215235
Start Date
October 18 2023
End Date
May 1 2026
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ErasmusMC
Rotterdam, Netherlands, 3015 GD